Phase II study of S-1 for elderly patients with unresectable pancreatic cancer

Trial Profile

Phase II study of S-1 for elderly patients with unresectable pancreatic cancer

Active, no longer recruiting
Phase of Trial: Phase II

Latest Information Update: 19 Sep 2013

At a glance

  • Drugs Gimeracil/oteracil/tegafur (Primary)
  • Indications Pancreatic cancer
  • Focus Therapeutic Use
  • Most Recent Events

    • 19 Sep 2013 Status changed from recruiting to active, no longer recruiting as reported by University Hospital Medical Information Network - Japan record.
    • 19 Mar 2013 Planned End Date 1 Apr 2014 added as reported by University Hospital Medical Information Network - Japan record.
    • 04 Oct 2011 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top